Natural bactericidal activity of human serum against Neisseria meningitidis isolates of different serogroups and serotypes.
We used a microtiter assay, standardized with serum-sensitive and serum-resistant strains of Neisseria gonorrhoeae, to determine the serum sensitivity of Neisseria meningitidis isolates of different serogroups and serotypes. Numbers of serum-resistant isolates varied among serogroups: group A = 7/8 (88%), group B = 26/50 (52%), group C = 5/8 (63%), group Y = 4/6 (67%), group W135 = 5/8 (63%), group 29E (Z') = 0/8 (0%), nongroupable isolates = 0/8 (0%). In comparison to group B isolates, group A isolates were more serum resistant (P less than 0.06), and group 29E and nongroupable isolates were more serum sensitive (P less than 0.001). Poor correlation was observed between serum sensitivity results and group-specific levels of bactericidal antibody in the normal human serum of volunteers. The frequency of serum-resistant strains among group B disease isolates (45%) was not significantly different from throat isolates of asymptomatic carriers (52%). Serotype 2 isolates of group B were no more serum resistant than were other serotypes examined. The serum sensitivity of meningococci appears to involve both capsular and noncapsular antigens and varies between serogroups. The increased serum sensitivity of nongroupable and group 29E isolates may account for the low incidence of disease caused by these organisms.
D000907:Antibodies, Bacterial / Q000032:analysis; D000942:Antigens, Bacterial / Q000276:immunology; D001770:Blood Bactericidal Activity; D006801:Humans; D009345:Neisseria meningitidis / Q000145:classification / Q000276:immunology / Q000502:physiology*; D012703:Serotyping
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial